when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer

July 2009

See updated FDA information concerning the use of 5-alpha reductase inhibitors and increased risk of serious forms of prostate cancer

Experts are debating when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer.

Proscar and Avodart. These 5-alpha-reductase inhibitors can prevent prostate cancer due to their anti-androgen effects.

At least one case of prostate cancer can be prevented for every 71 men treated for up to 7 years.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

debate about changing acetaminophen products and doses
Women's Health new warnings not to combine tamoxifen with certain SSRIs
Psychiatry increased risk of slow heart rate and fainting in patients taking cholinesterase inhibitors
Ophthalmology whether to use antibiotic eyedrops for conjunctivitis or "pink eye"
Dermatology possible skin-to-skin transfer of testosterone gels (AndroGel, Testim)
Cardiology how genetic variations and drug interactions may decrease the efficacy of clopidogrel (Plavix)
Men's Health when to use 5-alpha-reductase inhibitors (Proscar, Avodart) or PSA screening to prevent prostate cancer
Stroke More patients will be eligible to get tPA (alteplase) for acute ischemic stroke
Natural Health Products Does flaxseed have the same benefits as fish oils
Natural Health Products natural health products to help prevent or slow age-related macular degeneration (AMD)
Gastroenterology overuse of proton pump inhibitors (PPIs) and H2-blockers
Neurology & Pain change in appearance of fentanyl patches